Chartwell Investment Partners’s Gilead Sciences GILD Stock Holding History

Chartwell Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-39,000	Closed	-$2.76M	–	482
2018 Q2	$2.76M	Sell	39,000 -300	-0.8%	-$21.2K	0.08%	312
2018 Q1	$2.96M	Sell	39,300 -19,000	-33%	-$1.51M	0.1%	239
2017 Q4	$4.18M	Sell	58,300 -900	-2%	-$68.3K	0.14%	229
2017 Q3	$4.8M	Hold	59,200	–	–	0.16%	193
2017 Q2	$4.19M	Hold	59,200	–	–	0.16%	184
2017 Q1	$4.02M	Buy	59,200 +9,300	+19%	+$654K	0.15%	196
2016 Q4	$3.57M	Hold	49,900	–	–	0.12%	245
2016 Q3	$3.95M	Hold	49,900	–	–	0.07%	283
2016 Q2	$4.16M	Hold	49,900	–	–	0.07%	253
2016 Q1	$4.58M	Hold	49,900	–	–	0.09%	211
2015 Q4	$5.05M	Sell	49,900 -150	-0.3%	-$15.6K	0.1%	210
2015 Q3	$4.92M	Hold	50,050	–	–	0.11%	210
2015 Q2	$5.86M	Sell	50,050 -6,420	-11%	-$702K	0.11%	210
2015 Q1	$5.54M	Buy	56,470 +570	+1%	+$57.9K	0.11%	223
2014 Q4	$5.27M	Buy	55,900 +4,200	+8%	+$434K	0.11%	262
2014 Q3	$5.5M	Sell	51,700 -10,100	-16%	-$989K	0.12%	247
2014 Q2	$5.12M	Buy	+61,800	New	+$4.81M	0.11%	245

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chartwell Investment Partners's GILD Position: Q3 2018 in Review

Chartwell Investment Partners sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 39,000 shares — an estimated $2.76M sold.

Chartwell Investment Partners first reported a position in GILD in Q2 2014 and held it in 17 quarters. The position peaked at $5.86M in Q2 2015. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

Chartwell Investment Partners reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
Chartwell Investment Partners sold 39,000 Gilead Sciences shares in Q3 2018, an estimated $2.76M.
Chartwell Investment Partners first reported a position in Gilead Sciences in Q2 2014 and held it in 17 quarters.
Chartwell Investment Partners's Gilead Sciences position peaked at $5.86M in Q2 2015.
1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Chartwell Investment Partners's 13F filing for Q3 2018, filed 8 Nov 2018.